Literature DB >> 11215054

Expression of p53 and p21 protein in transitional mucosa adjacent to rectal carcinoma and its clinical implication.

M Feng1, F Pei, G Yang, Z Mao, S Wang.   

Abstract

To study the biopathological characteristics of the transitional mucosa adjacent to rectal carcinoma, 34 cases were subjected to mucin histochemical and immunohistochemical study to observe the expression of p53 and p21 protein in distal mucosa adjacent to rectal carcinoma and its relationship to the mucin change. The expression of p53 protein was found in 29.4% (10/34) of distal transitional mucosa in the cytoplasm of goblet cells, and its positive staining was within 4 cm from carcinoma margin. All p53 positive mucosa was transitional mucosa. Overexpression of p21 protein was found in 26.5% (9/34) of distal transitional mucosa in cytoplasm of crypt cells, and its positive staining was within 2 cm from carcinoma margin. There was no relationship between the expression of p53 and p21 protein in carcinoma and that in transitional mucosa (P > 0.05). These findings indicated that there was aberrant alteration of p53 and p21 genes in transitional mucosa adjacent to colorectal carcinoma, which provided further evidence that transitional mucosa was an unstable pre-cancerous change. The aberrant mucin change and genetic alteration in distal mucosa of rectal cancer is within 4 cm.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11215054     DOI: 10.1007/bf02886996

Source DB:  PubMed          Journal:  J Tongji Med Univ        ISSN: 0257-716X


  8 in total

Review 1.  The biochemistry of ras p21.

Authors:  R J Grand; D Owen
Journal:  Biochem J       Date:  1991-11-01       Impact factor: 3.857

2.  Value of histochemical reactions for mucosubstances in the diagnosis of certain pathological conditions of the colon and rectum.

Authors:  M I Filipe
Journal:  Gut       Date:  1969-07       Impact factor: 23.059

3.  Immunohistochemical expression of mutant p53 oncogene in transitional mucosa adjacent to human colon cancer.

Authors:  S Baytner; B Mitmaker; P H Gordon; E Wang
Journal:  Clin Invest Med       Date:  1993-10       Impact factor: 0.825

4.  Association of Ki-ras mutation with differentiation and tumor-formation pathways in colorectal carcinoma.

Authors:  P Laurent-Puig; S Olschwang; O Delattre; P Validire; T Melot; V Mosseri; R J Salmon; G Thomas
Journal:  Int J Cancer       Date:  1991-09-09       Impact factor: 7.396

5.  Expression of p53 protein in invasive colorectal carcinomas of different histologic types.

Authors:  C Hanski; G Bornhoeft; T Shimoda; M L Hanski; D P Lane; H Stein; E O Riecken
Journal:  Cancer       Date:  1992-12-15       Impact factor: 6.860

6.  p53 protein expression in transitional mucosa and adenocarcinomas of the colorectum.

Authors:  J H Connelly; J M Bruner; S S Robey-Cafferty; A Sahin
Journal:  Mod Pathol       Date:  1992-09       Impact factor: 7.842

7.  Prognostic significance of cytoplasmic p53 oncoprotein in colorectal adenocarcinoma.

Authors:  X F Sun; J M Carstensen; H Zhang; O Stål; S Wingren; T Hatschek; B Nordenskjöld
Journal:  Lancet       Date:  1992-12-05       Impact factor: 79.321

8.  Mucosal field change in colorectal cancer.

Authors:  P M Dawson; N A Habib; H C Rees; C B Wood
Journal:  Am J Surg       Date:  1987-03       Impact factor: 2.565

  8 in total
  1 in total

1.  p16INK4a gene promoter hypermethylation in mucosa as a prognostic factor for patients with colorectal cancer.

Authors:  Yvonne Wettergren; Elisabeth Odin; Staffan Nilsson; Göran Carlsson; Bengt Gustavsson
Journal:  Mol Med       Date:  2008 Jul-Aug       Impact factor: 6.354

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.